Wainzua

Wainzua (eplontersen sodium) is a subcutaneous injection for polyneuropathy of hereditary transthyretin-mediated amyloidosis. This rare disease can cause nerve damage and requires ongoing management. Eplontersen sodium helps reduce symptoms and slow progression in adults.

Eplontersen sodium is used to treat polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It helps manage symptoms and may slow disease progression. This medication is designed for long-term use under medical supervision.

Patients using eplontersen sodium may experience reduced pain and improved nerve function over time. Common effects include mild injection-site reactions and fatigue. These effects vary by individual and should be monitored by a healthcare provider.

Keep eplontersen sodium refrigerated until use and protect from light. Do not freeze or shake the vial or pen. Discard any unused medication after the expiration date. Always follow storage instructions to maintain potency and safety.

Eplontersen sodium may interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Avoid alcohol while using this medication, as it may worsen side effects. Consult a healthcare provider before combining with other therapies.